1. Adding standards for drug compendia for physician use for purposes of payment under Medicaid for certain drugs (a) In general Section 1927(g)(1)(B)(i) of the Social Security Act ( 42 U.S.C. 1396r–8(g)(1)(B)(i) ) is amended— (1) in subclause (I), by striking the semicolon at the end and inserting a period; (2) in subclause (II), by striking ); and at the end and inserting ). ; (3) in subclause (III)— (A) by striking the DRUGDEX and inserting The DRUGDEX ; and (B) by striking ; and at the end and inserting a period; and (4) by adding at the end the following: (IV) Other compendia, as determined by the Secretary in a manner consistent with the revision process provided for in section 1861(t), that— (aa) are utilized nationwide by the private health insurance industry; (bb) are used by health care providers, such as long-term care facilities or academic health centers; (cc) have a publicly available policy on the disclosure of conflicts of interest that may exist between such a health care provider and drug manufacturers; and (dd) are accepted as professional drug compendia by at least one State board of pharmacy (or an equivalent State licensing body). . (b) Technical amendments Section 1927(g)(1)(B) of the Social Security Act ( 42 U.S.C. 1396r–8(g)(1)(B) ) is amended— (1) in clause (i), by striking compendia and inserting Compendia ; and (2) in clause (ii), by striking the peer-reviewed and inserting The peer-reviewed . 2. Revising definition of medically accepted indication for Medicare Part D drugs Section 1860D–2(e)(4) of the Social Security Act ( 42 U.S.C. 1395w–102(e)(4) ) is amended— (1) in subparagraph (A)(i)(II), by striking section 1927(g)(1)(B)(i)(III) and inserting subclauses (III) and (IV) of section 1927(g)(1)(B)(i)